In CHD pathogenesis, the roles of ADRB3, SCYA11, and PON2 gene variants, which are related to energy and lipoprotein metabolisms, vascular and endothelial pathology, and antioxidant mechanisms, respectively, appeared to be complementary. This evidence concerns the gene ADRB3 and coronary artery disorder.